Established in the year 2003, we, Cian Healthcare Private Limited, are one of the trusted WHO-GMP & ISO-9001:2008 certified manufacturers, contract manufacturer, exporters and distributors of a supreme quality range of Pharmaceutical Products. In addition to this, we render excellent services for Third Party Pharmaceutical Manufacturing and Pharma Designing & Software Solutions.
Our products are formulated at our sophisticated processing unit, using high quality ingredients procured from the licensed vendors of the industry. Widely recommended by medical practitioners, these products are highly demanded for their accurate pH value, purity, accurate composition, efficacy and extended shelf life.
Moreover, we offer services with perfection by employing latest technology and methodology.
Our organization has 150 promotional distributors as well as 200 Third Party client. We have 600 brands of our own, comprising 11 divisions.
Moreover, we are engaged in Institutional Business especially for govt., semi govt.
CIAN HEALTHCARE PVT
and private institutions. Our organization has formed a tie-up with more than 200 clients for contract manufacturing and has launched more than 200 pharma companies successfully.
Since our establishment, we have given due preference to maintain consistent quality in the products and services offered by us. We always adhere to ethical trade practices and client-centric approach in all our business operations.
Suraj Zanwar” is the pillars of our organization. They always provide the necessary guidance and assistance to all the people associated with us.
Cian healthcare pvt ltd ipo
Cian is a WHO-GMP & ISO-9001:2008 certified transnational manufacturing company with a wide range of pharmaceutical, nutraceutical and food supplement products. Cian has a full fledged R & D and regulatory department.
Cian has developed 150 products and around 50 products under development for Global Market.
Cian is in process of rapid expansion of its global business and has registered and in process of registering around 100 formulations globally, also looking forward to register more innovative products in next two years, covering South East Asia, C.I.S., African and Latin American Countries.
Cian caters to eight segments of pharma industry (branches of medicines) including 500 brands across 11 product lines.
Cian's revenue has grown from `0.17 Million US$ in financial year 2008 to `8 Million US$ in FY 2014-15 and a CAGR of 55%.
Further the Company plans to reach 100 Million US$ by 2020.
Cian has various business models including Direct Marketing, Contract Manufacturing, Institutional, Franchisee and Exports.
Further a novel concept called 'Start your own pharma Company' initiated by Cian has generated good interest. Transformation in business model over the past few years has led to the exponential growth of the Company.